FDA•Aug 28, 2026Revcovi (elapegademase-lvlr) InjectionChiesi USA recalls Revcovi ( elapegademase-lvlr) Injection over failed stability specifications.
FDA•Jul 14, 2026MODERATECleviprex Injectable EmulsionChiesi USA is recalling Cleviprex (clevidipine injectable emulsion) 50 mg/100 mL vials due to a lack of assurance of sterility.
FDA•Mar 30, 2026MODERATECurosurf (poractant alfa) 240 mg Intratracheal SuspensionChiesi USA is recalling Curosurf 240 mg intratracheal suspension vials (NDC 10122-510-03) due to lack of sterility assurance.
